cancer therapeutics
cancer therapeutics
LOTTE BIOLOGICS Partners with Ottimo for Cancer Drug!
🌟 Exciting news! LOTTE BIOLOGICS partners with Ottimo Pharma to manufacture antibody therapeutics. 🚀 Together, they’re advancing cancer treatment! 🧬📦
Revolutionary TFF Boosts mRNA Purity and Production!
Optimizing TFF enhances mRNA purification! 🚀 Minimized fouling achieves 3 loss, boosting cost-effective vaccine production. 💉🔬 mRNA Biotech
Revolutionizing mRNA: A Breakthrough in Biologics!
🌟 Discover how Ginkgo Bioworks and TriLink BioTechnologies are revolutionizing mRNA manufacturing for better vaccines and therapeutics! 🚀🔬💡
Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪
Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!
📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍
Firefly Raises $94 Million to Revolutionize Cancer Treatment
🔥 Firefly secures $94m 💼 to develop antibody conjugates ⚡️ for precision medicines targeting cancer and other diseases. 🌍
Groundbreaking $800m Cancer Partnership Revolutionizes Treatment
🔍 Sorry, the requested page cannot be found. Please go back to the home page. 🏠 AstellasXyphos Kelonia CancerResearch Partnership
Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient
🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.
Revolutionary Kyverna Cuts CAR-T Production to 3 Days
📰 CAR-T, a gamechanger in cancer treatment, could revolutionize patient access and save lives with Kyverna's 3-day process. 💉🔬
Massive Growth in UK ADC Facility Boosts Biopharmaceutical Industry
📰 CDMO Piramal bulks out UK ADC facility! 💊🧪 Enhanced capabilities to meet growing demand in biopharmaceutical industry. 🌍👥
